GB1492445A - Immunochemically purified derivatives of human chorionic gonadotropin - Google Patents
Immunochemically purified derivatives of human chorionic gonadotropinInfo
- Publication number
- GB1492445A GB1492445A GB19098/75A GB1909875A GB1492445A GB 1492445 A GB1492445 A GB 1492445A GB 19098/75 A GB19098/75 A GB 19098/75A GB 1909875 A GB1909875 A GB 1909875A GB 1492445 A GB1492445 A GB 1492445A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chorionic gonadotropin
- human chorionic
- hormone
- derivative
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000011022 Chorionic Gonadotropin Human genes 0.000 title abstract 3
- 108010062540 Chorionic Gonadotropin Proteins 0.000 title abstract 3
- 229940084986 human chorionic gonadotropin Drugs 0.000 title abstract 3
- 239000003688 hormone derivative Substances 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 210000004900 c-terminal fragment Anatomy 0.000 abstract 1
- 239000003941 gonadotropin derivative Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 150000002828 nitro derivatives Chemical class 0.000 abstract 1
- 229960000814 tetanus toxoid Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1492445 Human chorionic gonadotropin derivatives ALL INDIA INSTITUTE OF MEDICAL SCIENCES 7 May 1975 [14 Oct 1974 28 Jan 1975] 19098/75 Heading A5B A composition comprises a conjugate of a subject compatible immunogenic carrier and an immunochemically purified hormone derivative which is (a) the # sub unit of human chorionic gonadotropin, (b) the C terminal fragments of (a) having 30-38 amino acid residues, or (c) the nitro derivative of (a), the hormone derivative being free of determinants capable of reacting with anti luternising hormone sera. The carrier may be tetanus toxoid, in ratio to (a) of 1:5 to 1:20.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2287/CAL/74A IN140168B (en) | 1974-10-14 | 1974-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1492445A true GB1492445A (en) | 1977-11-16 |
Family
ID=11087405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB19098/75A Expired GB1492445A (en) | 1974-10-14 | 1975-05-07 | Immunochemically purified derivatives of human chorionic gonadotropin |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE831786A (en) |
GB (1) | GB1492445A (en) |
IN (2) | IN140168B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470773A1 (en) * | 1979-11-28 | 1981-06-12 | Pasteur Institut | |
FR2498192A2 (en) * | 1981-01-22 | 1982-07-23 | Pasteur Institut | NOVEL POLYPEPTIDE THIOLE COMPOUND FROM A FRAGMENT OF TETANIC TOXIN, PROCESS FOR OBTAINING SAME AND APPLICATIONS THEREOF |
EP0117934A1 (en) * | 1983-03-04 | 1984-09-12 | The Ohio State University | Antigenic modification of polypeptides |
EP0178841A2 (en) * | 1984-10-11 | 1986-04-23 | University Of Southern California | Intragonadal regulatory protein |
US4780312A (en) * | 1985-06-04 | 1988-10-25 | National Institute Of Immunology | Birth control vaccine |
EP0326111A2 (en) * | 1988-01-29 | 1989-08-02 | New York Blood Center, Inc. | Peptide derivatives rendered immunogenic when administered with alum as an adjuvant |
-
1974
- 1974-10-14 IN IN2287/CAL/74A patent/IN140168B/en unknown
-
1975
- 1975-05-07 GB GB19098/75A patent/GB1492445A/en not_active Expired
- 1975-07-28 BE BE2054479A patent/BE831786A/en not_active IP Right Cessation
- 1975-12-22 IN IN2371/CAL/75A patent/IN140169B/en unknown
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0030496B1 (en) * | 1979-11-28 | 1983-07-13 | Institut Pasteur | Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications |
FR2470773A1 (en) * | 1979-11-28 | 1981-06-12 | Pasteur Institut | |
US4479940A (en) * | 1981-01-22 | 1984-10-30 | Institut Pasteur | Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications |
FR2498192A2 (en) * | 1981-01-22 | 1982-07-23 | Pasteur Institut | NOVEL POLYPEPTIDE THIOLE COMPOUND FROM A FRAGMENT OF TETANIC TOXIN, PROCESS FOR OBTAINING SAME AND APPLICATIONS THEREOF |
EP0057140A2 (en) * | 1981-01-22 | 1982-08-04 | Pasteur Institut | Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications |
EP0057140A3 (en) * | 1981-01-22 | 1982-08-25 | Pasteur Institut | Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications |
GB2146646A (en) * | 1983-03-04 | 1985-04-24 | Univ Ohio State | Antigenic modification of polypeptides |
WO1984003443A1 (en) * | 1983-03-04 | 1984-09-13 | Univ Ohio State | Antigenic modification of polypeptides |
EP0117934A1 (en) * | 1983-03-04 | 1984-09-12 | The Ohio State University | Antigenic modification of polypeptides |
EP0210628A2 (en) * | 1983-03-04 | 1987-02-04 | The Ohio State University | Antigenic modification of polypeptides |
EP0213391A2 (en) * | 1983-03-04 | 1987-03-11 | The Ohio State University | Antigenic modification of polypeptides |
EP0213391A3 (en) * | 1983-03-04 | 1989-02-01 | The Ohio State University | Antigenic modification of polypeptides |
EP0210628A3 (en) * | 1983-03-04 | 1989-02-08 | The Ohio State University | Antigenic modification of polypeptides |
EP0178841A2 (en) * | 1984-10-11 | 1986-04-23 | University Of Southern California | Intragonadal regulatory protein |
EP0178841A3 (en) * | 1984-10-11 | 1987-05-27 | University Of Southern California | Intragonadal regulatory protein |
US4780312A (en) * | 1985-06-04 | 1988-10-25 | National Institute Of Immunology | Birth control vaccine |
EP0326111A2 (en) * | 1988-01-29 | 1989-08-02 | New York Blood Center, Inc. | Peptide derivatives rendered immunogenic when administered with alum as an adjuvant |
EP0326111A3 (en) * | 1988-01-29 | 1989-12-27 | New York Blood Center, Inc. | Peptide derivatives rendered immunogenic when administered with alum as an adjuvant |
Also Published As
Publication number | Publication date |
---|---|
BE831786A (en) | 1975-11-17 |
IN140169B (en) | 1976-09-25 |
IN140168B (en) | 1976-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE44190L (en) | Glucosamine derivatives | |
EP0248887A4 (en) | Cell-free t cell antigen receptor and its clinical utilities. | |
CA2006818A1 (en) | Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them | |
MY110665A (en) | Combined vaccines comprising hepatitis b surface antigen and other antigen | |
IE42382L (en) | Cyclic amino acids | |
PT82173A (en) | Process for preparing novel peptides | |
ES8506451A1 (en) | Process for the preparation of lyophilized, adsorbed polyvalent vaccines | |
AU8390375A (en) | Administering amino acid ackyl esters | |
GB1492445A (en) | Immunochemically purified derivatives of human chorionic gonadotropin | |
IE42340L (en) | 11,12-secoprostaglandins | |
GB1531014A (en) | Oil-free adjuvant composition | |
AU497698B2 (en) | Administering gas toa patient | |
SE8204874D0 (en) | PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMANT PROINSULIN | |
SE8204873L (en) | PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE | |
AU6756287A (en) | Nicorandil-containing preparation for injection | |
NZ235316A (en) | Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection | |
NO800724L (en) | PROCEDURE FOR PREPARING PEPTIDES WITH UBIQUIT-SIMILAR ACTIVITY | |
AU525695B2 (en) | Pharmaceutical formulations of prostacyclin | |
KR890008171A (en) | Peptide constructs, immunogens containing them and their use in inhibiting fertility | |
EP0565146A3 (en) | Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes | |
WO1995032286A3 (en) | Immunogenic carcinoembryonic antigen and methods of use and production | |
IT1060502B (en) | PROCEDURE FOR THE PREPARATION OF HIGH BLACK CARBON AND LOW IMPURITY CONTENT | |
GB2004744A (en) | Immunological preparations containing major histocompatibility complex antigen | |
AU554859B2 (en) | Polymerized albumin vaccine | |
FR2319379A1 (en) | Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |